Abciximab readministration: results of the ReoPro Readministration Registry. (Record no. 11438937)

MARC details
000 -LEADER
fixed length control field 02165 a2200601 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250514005552.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200109s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1524-4539
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1161/hc3301.094533
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Tcheng, J E
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20010913
245 00 - TITLE STATEMENT
Title Abciximab readministration: results of the ReoPro Readministration Registry.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Circulation
Date of publication, distribution, etc. Aug 2001
300 ## - PHYSICAL DESCRIPTION
Extent 870-5 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Clinical Trial, Phase IV; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Abciximab
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Angioplasty, Balloon, Coronary
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aspirin
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Coronary Disease
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Disease-Free Survival
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Administration Schedule
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hemorrhage
General subdivision etiology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Heparin
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Immunoglobulin Fab Fragments
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Platelet Aggregation
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Platelet Aggregation Inhibitors
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Platelet Glycoprotein GPIIb-IIIa Complex
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Postoperative Complications
General subdivision prevention & control
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Registries
General subdivision statistics & numerical data
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Thrombocytopenia
General subdivision diagnosis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element United States
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Vascular Patency
General subdivision drug effects
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kereiakes, D J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lincoff, A M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name George, B S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kleiman, N S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sane, D C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Cines, D B
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Jordan, R E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mascelli, M A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Langrall, M A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Damaraju, L
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Schantz, A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Effron, M B
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Braden, G A
773 0# - HOST ITEM ENTRY
Title Circulation
Related parts vol. 104
-- no. 8
-- p. 870-5
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1161/hc3301.094533">https://doi.org/10.1161/hc3301.094533</a>
Public note Available from publisher's website

No items available.